Learn more about whether Catalyst Pharmaceuticals, Inc. or Ionis Pharmaceuticals, Inc. is a better investment based on AAII's ...

Lynne Marie Sullivan, the CFO and Head of Corporate Development at Unity Biotechnology, Inc. (NASDAQ:UBX), recently sold shares of the company. According to a recent filing, Sullivan sold 153 shares ...

Anirvan Ghosh, the Chief Executive Officer of Unity Biotechnology, Inc. (NASDAQ:UBX), recently sold 642 shares of the company's common stock. The biotech company, currently valued at $38.42 million, ...

Belite Bio is a biotech firm specializing in innovative therapies for retinal degenerative eye diseases with high unmet needs ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued stocks in the Biotechnology industry for Wednesday, February 05, 2025. Let’s ...

Aurion Biotech, Inc. plans $100M IPO for corneal disease treatments, limited competition, Phase 1/2 trials underway with ...

Low-cost passive index investing (in the S&P 500 or Nasdaq 100) has been key to impressive results in recent years. However, ...

Of the 102 company launches or series A financings since October 2023, just nine had a woman at the helm, according to a ...

MarketSmith India recommends these two stocks for Wednesday, 5 February.

Equities researchers at HC Wainwright issued their FY2029 EPS estimates for shares of Evaxion Biotech A/S in a research note issued to investors on Monday, February 3rd. HC Wainwright analyst S.

Shares of Amgen (AMGN) fell in after-hours trading after the biotechnology company reported earnings for its fourth quarter ...

Amgen reported strong fourth-quarter earnings, driven by strategic acquisitions and robust product sales growth.